{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:39:15Z","timestamp":1768001955453,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10120-015-0506-z","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T06:58:42Z","timestamp":1442559522000},"page":"350-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial)"],"prefix":"10.1007","volume":"19","author":[{"given":"Nobuhiko","family":"Tanigawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yamaue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigekazu","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Sakuramoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Inada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuh","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisho","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"San-Woong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifusa","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"506_CR1","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, on oral fluoropyrimidine. N Engl J Med. 2007;357:1810\u201320.","journal-title":"N Engl J Med"},{"key":"506_CR2","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako M, Sakuramoto S, Takai H, Kinoshita T, Furukawa H, Yamaguchi T, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387\u201393.","journal-title":"J Clin Oncol"},{"key":"506_CR3","first-page":"2309","volume":"44","author":"N Tanigawa","year":"1984","unstructured":"Tanigawa N, Mizuno Y, Hashimura T, Honda K, Satomura K, Hikasa Y, et al. Comparison of drug sensitivity among tumor cells within a tumor, between primary and metastases, and between different metastases in the human tumor-colony forming assay. Cancer Res. 1984;44:2309\u201312.","journal-title":"Cancer Res"},{"key":"506_CR4","first-page":"423","volume":"22","author":"C Trope","year":"1975","unstructured":"Trope C, Hakansson L, Dencker H. Heterogeneity of human adenocarcinomas of the colon and the stomach as regards sensitivity to cytostatic drugs. Neoplasma. 1975;22:423\u201330.","journal-title":"Neoplasma"},{"key":"506_CR5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0014-2964(80)90205-4","volume":"16","author":"A Blorklund","year":"1980","unstructured":"Blorklund A, Hakansson L, Stenstam B, Trope C, Akerman M. On heterogeneity of non-Hodgkin\u2019s lymphomas as regards sensitivity to cytostatic drugs. An in vitro study. Eur J Cancer. 1980;16:647\u201354.","journal-title":"Eur J Cancer"},{"key":"506_CR6","first-page":"3058","volume":"41","author":"T Tsuruo","year":"1981","unstructured":"Tsuruo T, Fidler IJ. Differences in drug sensitivity among tumor cells from parental tumors, selected varients, and spontaneous metastases. Cancer Res. 1981;41:3058\u201364.","journal-title":"Cancer Res"},{"key":"506_CR7","first-page":"2159","volume":"42","author":"N Tanigawa","year":"1982","unstructured":"Tanigawa N, Kern DH, Hikasa Y, Morton DL. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res. 1982;42:2159\u201364.","journal-title":"Cancer Res"},{"key":"506_CR8","first-page":"1725","volume":"44","author":"VK Sondak","year":"1984","unstructured":"Sondak VK, Bertelsen CA, Tanigawa N, Hilderbrand-Zanki SU, Morton DL, Kern DH. Clinical correlation with chemosensitivities measured in a rapid thymidine incorporation assay. Cancer Res. 1984;44:1725\u201332.","journal-title":"Cancer Res"},{"key":"506_CR9","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1073\/pnas.88.12.5163","volume":"88","author":"RA Vescio","year":"1991","unstructured":"Vescio RA, Connors KM, Kubota T, Hoffman RM. Correlation of histology and drug response of human tumors grown in native-state three-dimensional histoculture and in nude mice. Proc Natl Acad Sci U S A. 1991;88:5163\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"506_CR10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/bjc.1992.362","volume":"66","author":"H Yamaue","year":"1992","unstructured":"Yamaue H, Tanimura H, Noguchi K, Hotta T, Tani M, Tsunoda T, et al. Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. Br J Cancer. 1992;66:794\u20139.","journal-title":"Br J Cancer"},{"key":"506_CR11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000423477","volume":"19","author":"LM Weisenthal","year":"1994","unstructured":"Weisenthal LM. Clinical correlations for cell culture assays based on the concept of total cell kill. Contrib Gynecol Obstet. 1994;19:82\u201390.","journal-title":"Contrib Gynecol Obstet"},{"key":"506_CR12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF02054057","volume":"39","author":"H Yamaue","year":"1996","unstructured":"Yamaue H, Tanimura H, Nakamori M, Noguchi K, Iwahashi M, Tani M, et al. Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay. Dis Colon Rectum. 1996;39:416\u201322.","journal-title":"Dis Colon Rectum"},{"key":"506_CR13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/PL00012034","volume":"5","author":"T Kondo","year":"2000","unstructured":"Kondo T, Yamauchi M, Tominaga S. Evaluation of usefulness of in vitro drug sensitivity testing for adjuvant chemotherapy of stomach cancer. Int J Clin Oncol. 2000;5:174\u201382.","journal-title":"Int J Clin Oncol"},{"key":"506_CR14","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.1999.17.5.1625","volume":"17","author":"P Cortazar","year":"1999","unstructured":"Cortazar P, Johnson BE. Reviews of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer. J Clin Oncol. 1999;17:1625\u201331.","journal-title":"J Clin Oncol"},{"key":"506_CR15","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2004.04.077","volume":"22","author":"DJ Samson","year":"2004","unstructured":"Samson DJ, Seidenfeld J, Ziegler K, Aronson N. Chemotherapy sensitivity and resistance assays: a systemic review. J Clin Oncol. 2004;22:3618\u201330.","journal-title":"J Clin Oncol"},{"key":"506_CR16","unstructured":"Japanese Gastric Cancer Association: Gastric cancer treatment guidelines 2010. Tokyo: Kanehara; 2010."},{"key":"506_CR17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/PL00011681","volume":"1","author":"Japanese Gastric Cancer Association","year":"1998","unstructured":"Association Japanese Gastric Cancer. Japanese classification of gastric carcinoma \u2013 2nd English edition \u2013. Gastric Cancer. 1998;1:10\u201324.","journal-title":"Gastric Cancer"},{"key":"506_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10120-010-0564-1","volume":"13","author":"K Maejima","year":"2010","unstructured":"Maejima K, Tokunaga A, Kiyama T, Kanno H, Bou H, Watanabe M, et al. Chemosensitivity test for 5-fluorouracil and 5-chloro-2,4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively. Gastric Cancer. 2010;13:231\u20137.","journal-title":"Gastric Cancer"},{"key":"506_CR19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s10120-013-0320-4","volume":"7","author":"H Naitoh","year":"2014","unstructured":"Naitoh H, Yamamoto H, Murata S, Kobayashi H, Inoue K, Tani T. Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer. Gastric Cancer. 2014;7:630\u20137.","journal-title":"Gastric Cancer"},{"key":"506_CR20","first-page":"671","volume":"23","author":"F Gu","year":"2010","unstructured":"Gu F, Ma Y, Zhang Z, Zhao J, Kobayashi H, Zhang L, et al. Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. Oncol Rep. 2010;23:671\u20136.","journal-title":"Oncol Rep"},{"key":"506_CR21","first-page":"355","volume":"14","author":"M Higashiyama","year":"2008","unstructured":"Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Takami K, et al. In vitro chemosensitivity test using the collagen gel droplet-embedded drug sensitivity test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application. Ann Thorac Cardiovasc Surg. 2008;14:355\u201362.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"506_CR22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.lungcan.2009.07.005","volume":"68","author":"M Higashiyama","year":"2010","unstructured":"Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Imamura F, et al. Predication of chemosetherapeutic effect on postoperative small cell lung cancer patients. Lung Cancer. 2010;68:472\u20137.","journal-title":"Lung Cancer"},{"key":"506_CR23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00280-006-0292-8","volume":"59","author":"M Kawamura","year":"2007","unstructured":"Kawamura M, Gika M, Abiko T, Inoue Y, Oyama T, Izumi Y, et al. Clinical evaluation of chemosensitivity test for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture-drug sensitivity test (CD-DST). Cancer Chemother Pharmacol. 2007;59:507\u201313.","journal-title":"Cancer Chemother Pharmacol"},{"key":"506_CR24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.10208","volume":"98","author":"Y Takamura","year":"2002","unstructured":"Takamura Y, Kobayashi H, Taguchi T, Motoyama K, Inaji H, Noguchi S. Prediction of chemotherapeutic response by collagen gel droplet embedded culture drug sensitivity test in human breast cancers. Int J Cancer. 2002;98:450\u20135.","journal-title":"Int J Cancer"},{"key":"506_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1349-7006.2001.tb01083.x","volume":"92","author":"H Kobayashi","year":"2001","unstructured":"Kobayashi H, Higashiyama M, Minamigawa K, Tanisaka K, Takano T, Yokouchi H, et al. Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification. Jpn J Cancer Res. 2001;92:203\u201310.","journal-title":"Jpn J Cancer Res"},{"key":"506_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/978-3-642-19022-3_5","volume":"161","author":"H Kobayashi","year":"2003","unstructured":"Kobayashi H. Development of a new in vitro chemosensitivity test using collagen gel droplet embedded culture and image analysis for clinical usefulness. Recent Results Cancer Res. 2003;161:48\u201361.","journal-title":"Recent Results Cancer Res"},{"key":"506_CR27","first-page":"2203","volume":"47","author":"GD Heggie","year":"1987","unstructured":"Heggie GD, Sommadossi JP, Cross DS, Huster WJ, Diasio RB. Clinical pharmacokineticsof 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res. 1987;47:2203\u20136.","journal-title":"Cancer Res"},{"key":"506_CR28","first-page":"73","volume":"473","author":"PV Danenberg","year":"1977","unstructured":"Danenberg PV. Thymidilate synthase\u2013\u2013a target enzyme in cancer chemotherapy. Biochem Biophys Acta. 1977;473:73\u201392.","journal-title":"Biochem Biophys Acta"},{"key":"506_CR29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0065-230X(08)60036-6","volume":"46","author":"GJ Peters","year":"1986","unstructured":"Peters GJ, Laurensse E, Leyva A, Lankelma J, Pnedo HM. Sensivity of human, murine, and rat cells drug metabolizing enzymes. Cancer Res. 1986;46:20\u20138.","journal-title":"Cancer Res"},{"key":"506_CR30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.canlet.2007.01.006","volume":"252","author":"Y Kodera","year":"2007","unstructured":"Kodera Y, Ito S, Fujiwara M, Mochizuki Y, Nakayama G, Ohashi N, et al. Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil. Cancer Lett. 2007;252:307\u201313.","journal-title":"Cancer Lett"},{"key":"506_CR31","first-page":"1537","volume":"1","author":"T Kubota","year":"1995","unstructured":"Kubota T, Sasano N, Abe O, Nakao I, Kawamura E, Saito T, et al. Potential of the histoculture drug-response assay to contribute to cancer patient survival. Clin Cancer Res. 1995;1:1537\u201343.","journal-title":"Clin Cancer Res"},{"key":"506_CR32","first-page":"305","volume":"1","author":"T Furukawa","year":"1995","unstructured":"Furukawa T, Kubota T, Hoffman RM. Clinical applications of the histoculture drug response assay. Clin Cancer Res. 1995;1:305\u201311.","journal-title":"Clin Cancer Res"},{"key":"506_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006122912146","volume":"53","author":"JM Xu","year":"1999","unstructured":"Xu JM, Song ST, Tang ZM, Jiang ZF, Liu XQ, Zhou L, et al. Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro. Breast Cancer Res Treat. 1999;53:77\u201385.","journal-title":"Breast Cancer Res Treat"},{"key":"506_CR34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00001813-199801000-00006","volume":"9","author":"CM Kurbacher","year":"1998","unstructured":"Kurbacher CM, Cree IA, Bruckner HW, Brenne U, Kurbacher JA, Muller K, et al. Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anticancer Drugs. 1998;9:51\u20137.","journal-title":"Anticancer Drugs"},{"key":"506_CR35","first-page":"449","volume":"11","author":"H Kobayashi","year":"1997","unstructured":"Kobayashi H, Tanisaka K, Doi O, Kodama K, Higashiyama M, Nakagawa H, et al. An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. Int J Oncol. 1997;11:449\u201355.","journal-title":"Int J Oncol"},{"key":"506_CR36","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1200\/JCO.2004.05.065","volume":"12","author":"D Schrag","year":"2004","unstructured":"Schrag D, Garewal HS, Burstein HJ, Samson DJ, Von Hoff DD, Somerfield. ASCO working group on chemotherapy sensitivity and resistance assays. American Society of Clinical Oncology technology assessment: chemotherapy sensitivity and resistance assays. J Clin Oncol. 2004;12:3631\u20138.","journal-title":"J Clin Oncol"},{"key":"506_CR37","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1200\/JCO.2005.05.281","volume":"23","author":"JP Fruehauf","year":"2005","unstructured":"Fruehauf JP, Alberts DS. In vitro drug resistance versus chemosensitivity: two sides of different coins. J Clin Oncol. 2005;23:3646\u20138.","journal-title":"J Clin Oncol"},{"key":"506_CR38","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1158\/1078-0432.CCR-05-2763","volume":"12","author":"S Ugurel","year":"2006","unstructured":"Ugurel S, Schadendorf D, Pfohler C, Neuber K, Thoelke A, Ulrich J, et al. In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermotologic Cooperative Oncology Group. Clin Cancer Res. 2006;12:5454\u201363.","journal-title":"Clin Cancer Res"},{"key":"506_CR39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10147-006-0618-x","volume":"11","author":"Y Kodera","year":"2006","unstructured":"Kodera Y, Ito S, Fujiwara M, Mochizuki Y, Ohashi N, Ito Y, et al. In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues. In J Clin Oncol. 2006;11:449\u201353.","journal-title":"In J Clin Oncol"},{"key":"506_CR40","first-page":"1733","volume":"28","author":"Z Mi","year":"2008","unstructured":"Mi Z, Holmes FA, Hellerstedt B, Pippen J, Collea R, Backner A, et al. Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients. Anticancer Res. 2008;28:1733\u201340.","journal-title":"Anticancer Res"},{"key":"506_CR41","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.3748\/wjg.14.3064","volume":"14","author":"B Wu","year":"2008","unstructured":"Wu B, Zhu JS, Zhang Y, Shen WM, Zhang Q. Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: one institution\u2019s experience. World J Gastroenterol. 2008;14:3064\u20138.","journal-title":"World J Gastroenterol"},{"key":"506_CR42","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.2011.36.0354","volume":"29","author":"HJ Burstein","year":"2011","unstructured":"Burstein HJ, Mangu PB, Somerfield MR, Schrag D, Samson D, Holt L, et al. American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol. 2011;29:3328\u201330.","journal-title":"J Clin Oncol"},{"key":"506_CR43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SH. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315\u201321.","journal-title":"Lancet"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-015-0506-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-015-0506-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-015-0506-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T14:23:05Z","timestamp":1567174985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-015-0506-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1007\/s10120-015-0506-z","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,18]]}}}